(UFPT) UFP Technologies - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9026731029
UFPT: Medical, Packaging, Aerospace, Automotive, Defense
UFP Technologies, Inc. (NASDAQ:UFPT) is a leading developer and manufacturer of high-performance, custom-engineered products for the medical, aerospace and defense, industrial, and automotive sectors. Founded in 1963 and headquartered in Newburyport, Massachusetts, the company specializes in advanced materials and precision manufacturing to deliver innovative solutions. Its product portfolio includes robotic surgery drapes, patient handling systems, infection prevention materials, and custom packaging for medical devices. Additionally, UFP produces molded components for automotive applications such as load floors, sunshades, and acoustic insulation, leveraging its expertise in materials like DuPont Sorona®. The company also serves the aerospace and defense industries with lightweight composites for military gear, including backpack components, knee and elbow pads, and protective eyewear, as well as custom case systems for drones, communications equipment, and rugged portable computers.
UFP Technologies operates with a strong focus on research and development, ensuring its products meet stringent regulatory and performance standards. Its manufacturing capabilities include precision molding, 3D printing, and advanced composites, enabling the company to address complex customer requirements. UFPs direct sales force ensures close collaboration with clients, providing tailored solutions across its diverse markets. With a market capitalization of $1.612 billion and a return on equity of 17.21%, the company demonstrates strong financial health and operational efficiency.
3-Month Forecast: Based on the SMA and ATR data, UFPT is expected to experience moderate volatility with potential upside. The SMA 20 crossing below the SMA 50 indicates near-term weakness, but the narrowing gap between the two suggests stabilization. With an ATR of 12.13, price fluctuations are likely to remain contained. Support is anticipated around the SMA 50 level of 213.31, with resistance near the SMA 200 at 275.46. The stock may trade sideways in the near term, with a potential breakout if it breaches the 220 level.
Additional Sources for UFPT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
UFPT Stock Overview
Market Cap in USD | 1,558m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Supplies |
IPO / Inception | 1993-12-16 |
UFPT Stock Ratings
Growth Rating | 63.1 |
Fundamental | 60.3 |
Dividend Rating | 0.0 |
Rel. Strength | -3.22 |
Analysts | 4/5 |
Fair Price Momentum | 249.16 USD |
Fair Price DCF | 74.79 USD |
UFPT Dividends
No Dividends PaidUFPT Growth Ratios
Growth Correlation 3m | -63.9% |
Growth Correlation 12m | -55.6% |
Growth Correlation 5y | 97.5% |
CAGR 5y | 38.99% |
CAGR/Max DD 5y | 0.81 |
Sharpe Ratio 12m | 0.24 |
Alpha | -22.03 |
Beta | 1.655 |
Volatility | 58.10% |
Current Volume | 129.3k |
Average Volume 20d | 107.1k |
As of May 09, 2025, the stock is trading at USD 233.91 with a total of 129,277 shares traded.
Over the past week, the price has changed by +10.16%, over one month by +21.07%, over three months by -10.71% and over the past year by -7.16%.
Yes, based on ValueRay Fundamental Analyses, UFP Technologies (NASDAQ:UFPT) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 60.32 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of UFPT as of May 2025 is 249.16. This means that UFPT is currently overvalued and has a potential downside of 6.52%.
UFP Technologies has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy UFPT.
- Strong Buy: 1
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, UFPT UFP Technologies will be worth about 287 in May 2026. The stock is currently trading at 233.91. This means that the stock has a potential upside of +22.68%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 381 | 62.9% |
Analysts Target Price | 381 | 62.9% |
ValueRay Target Price | 287 | 22.7% |